LOADING

Type to search

Medically Compromised Patients Pharmacology Supporting Your Practice

Case Conference: How would you manage this case?

This case is presented by Dr. Aviv Ouanounou from the Faculty of Dentistry at the University of Toronto.

Watch the Case Presentation

 

We welcome your input about this topic. You have the option to remain anonymous in leaving your feedback. Please note that all your comments are moderated by the CDA Oasis Team and no comments go live immediately. Your feedback is sent to us in the form of an email which is accessed by the CDA Oasis Team and is not shared by a third party. You can safely leave your name and email allowing us to contact you, if needed, and that information will remain confidential at all times. 

Please leave a comment in the textbox below or contact us at oasisdiscussions@cda-adc.ca 

 

    Your Name (optional)

    Your Email (optional)

    What is the case’s differential diagnosis?

    Is there any other information needed to come up with a diagnosis and a treatment plan?

    How would you manage this case?

    Any other questions for Dr. Aviv Ouanounou?

    2 Comments

    1. Hamish Varshney September 15, 2015

      My initial impression would be oral leukoplakia. However, that is a clinical descriptor and not a diagnostic term. Could this be drug related? Does the patient smoke? Could this be due to irritation?
      I feel a biopsy would be necessary in determining a diagnosis for management. I am very interested in hearing the differential diagnosis and what was done to manage this condition.

      Reply
    2. Marie-Claude Cholette September 21, 2015

      Previous history of similar lesions?/ Skin lesions?/Smoking?

      As my first impression (based on appearance and history) is that the recent 8 weeks of antibiotherapy would have caused changes in oral flora, I would first suspect fungal infection (candidiadis).

      Considering that high likelyhood of fungal infection, I would first swab the lesions for culture and would prescribe anti-fungal agent (Nystatin), if lesions persist, biopsy would be indicated.

      Reply

    Leave a Comment Marie-Claude Cholette Cancel Comment

    Your email address will not be published. Required fields are marked *